THROMBOLYTIC SCIENCE INC has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are MICROVASCULAR TISSUES INC, ISOLAGEN TECHNOLOGIES INC and NOVOVASCULAR INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Object sterilising | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Gurewich Victor | 10 |
#2 | Sarmientos Paolo | 8 |
#3 | Liu Jian-Ning | 8 |
#4 | Pagani Massimiliano | 5 |
#5 | Williams John N | 4 |
#6 | Pannell Ralph | 2 |
#7 | Sareientos Paolo | 1 |
#8 | Victor Gurewich | 1 |
Publication | Filing date | Title |
---|---|---|
US2007298024A1 | C-1 inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thrombolysis | |
EP2180049A1 | Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase | |
US7070958B2 | Methods of making pro-urokinase mutants |